Eivor Elovaara

3.2k total citations
84 papers, 2.7k citations indexed

About

Eivor Elovaara is a scholar working on Pharmacology, Cancer Research and Molecular Biology. According to data from OpenAlex, Eivor Elovaara has authored 84 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Pharmacology, 34 papers in Cancer Research and 27 papers in Molecular Biology. Recurrent topics in Eivor Elovaara's work include Pharmacogenetics and Drug Metabolism (47 papers), Carcinogens and Genotoxicity Assessment (34 papers) and Analytical Chemistry and Chromatography (11 papers). Eivor Elovaara is often cited by papers focused on Pharmacogenetics and Drug Metabolism (47 papers), Carcinogens and Genotoxicity Assessment (34 papers) and Analytical Chemistry and Chromatography (11 papers). Eivor Elovaara collaborates with scholars based in Finland, France and Japan. Eivor Elovaara's co-authors include Harri Vainio, Tamie Nakajima, Jouni Mikkola, Harry V. Gelboin, H. Savolainen, Tamie Nakajima, Jyrki Taskinen, Ari Hirvonen, Hannu Raunio and Leena Luukkanen and has published in prestigious journals such as SHILAP Revista de lepidopterología, Analytical Chemistry and Environmental Health Perspectives.

In The Last Decade

Eivor Elovaara

82 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eivor Elovaara Finland 32 969 834 788 723 412 84 2.7k
Robert Snyder United States 31 1.7k 1.7× 1.2k 1.5× 593 0.8× 819 1.1× 232 0.6× 98 3.5k
Friedrich J. Wiebel Germany 30 873 0.9× 943 1.1× 1.1k 1.4× 610 0.8× 184 0.4× 85 2.6k
Philip L. Grover United Kingdom 31 1.6k 1.7× 1.4k 1.7× 492 0.6× 788 1.1× 230 0.6× 76 3.0k
H.B. Matthews United States 38 1.3k 1.3× 832 1.0× 851 1.1× 2.1k 2.8× 456 1.1× 138 4.5k
P.Th. Henderson Netherlands 31 1.6k 1.7× 679 0.8× 420 0.5× 1.5k 2.0× 416 1.0× 101 3.3k
Douglas E. Rickert United States 26 759 0.8× 596 0.7× 392 0.5× 634 0.9× 211 0.5× 91 2.4k
Anver D. Rahimtula Canada 29 478 0.5× 817 1.0× 525 0.7× 776 1.1× 489 1.2× 80 2.5k
Leo T. Burka United States 30 543 0.6× 1.1k 1.3× 556 0.7× 607 0.8× 322 0.8× 108 3.5k
Johannes Doehmer Germany 31 859 0.9× 1.2k 1.5× 1.2k 1.6× 444 0.6× 194 0.5× 106 2.9k
Masakuni Degawa Japan 26 671 0.7× 941 1.1× 754 1.0× 438 0.6× 278 0.7× 149 2.7k

Countries citing papers authored by Eivor Elovaara

Since Specialization
Citations

This map shows the geographic impact of Eivor Elovaara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eivor Elovaara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eivor Elovaara more than expected).

Fields of papers citing papers by Eivor Elovaara

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eivor Elovaara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eivor Elovaara. The network helps show where Eivor Elovaara may publish in the future.

Co-authorship network of co-authors of Eivor Elovaara

This figure shows the co-authorship network connecting the top 25 collaborators of Eivor Elovaara. A scholar is included among the top collaborators of Eivor Elovaara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eivor Elovaara. Eivor Elovaara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Elovaara, Eivor, Jouni Mikkola, Leena Luukkanen, et al.. (2004). ASSESSMENT OF CATECHOL INDUCTION AND GLUCURONIDATION IN RAT LIVER MICROSOMES. Drug Metabolism and Disposition. 32(12). 1426–1433. 14 indexed citations
4.
Anttila, Sisko, Päivi Tuominen, Ari Hirvonen, et al.. (2001). CYP1A1 levels in lung tissue of tobacco smokers and polymorphisms of CYP1A1 and aromatic hydrocarbon receptor. Pharmacogenetics. 11(6). 501–509. 63 indexed citations
5.
Möller, Lennart, M. Kantola, Raija Purkunen, et al.. (2000). DNA adducts in human placenta as biomarkers for environmental pollution, analysed by the32P-HPLC method. Biomarkers. 5(3). 182–191. 15 indexed citations
6.
Norppa, Hannu, et al.. (1999). Epoxide hydrolase activity in human blood mononuclear leukocytes: individual differences in native and mitogen-stimulated cells. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 444(2). 387–392. 3 indexed citations
7.
Nakajima, Tamie, Eivor Elovaara, Sisko Anttila, et al.. (1995). Expression and polymorphism of glutathione S-transferase in human lungs: risk factors in smoking-related lung cancer. Carcinogenesis. 16(4). 707–711. 152 indexed citations
8.
Elovaara, Eivor, et al.. (1995). Effect of cytochrome P450 isozyme induction and glutathione depletion on the metabolism of CS2 to TTCA in rats. Archives of Toxicology. 69(3). 185–190. 10 indexed citations
9.
Rizzo, Aldo, Faik Atroshi, Markku Ahotupa, S. Sankari, & Eivor Elovaara. (1994). Protective Effect of Antioxidants against Free Radical‐Mediated Lipid Peroxidation Induced by DON or T‐2 Toxin. Journal of Veterinary Medicine Series A. 41(1-10). 81–90. 151 indexed citations
10.
Nakajima, Tamie, Wang Rui-Sheng, Eivor Elovaara, et al.. (1994). CYP2C11 and CYP2B1 are major cytochrome P450 forms involved in styrene oxidation in liver and lung microsomes from untreated rats, respectively. Biochemical Pharmacology. 48(4). 637–642. 44 indexed citations
11.
Nakajima, Tamie, Eivor Elovaara, Frank J. Gonzalez, et al.. (1994). Styrene Metabolism by cDNA-Expressed Human Hepatic and Pulmonary Cytochromes P450. Chemical Research in Toxicology. 7(6). 891–896. 105 indexed citations
12.
Liira, Juha, Eivor Elovaara, Hannu Raunio, Vesa Riihimäki, & Kerstin Engström. (1991). Metabolic interaction and disposition of methyl ethyl ketone andm-xylene in rats at single and repeated inhalation exposures. Xenobiotica. 21(1). 53–63. 18 indexed citations
13.
Elovaara, Eivor, et al.. (1991). Distribution and effects on cytochrome P450 system of two hexachlorobiphenyl isomers in the rat. Archives of Toxicology. 65(8). 661–665. 2 indexed citations
14.
Raunio, Hannu, Juha Liira, Eivor Elovaara, Vesa Riihimäki, & Olavi Pelkonen. (1990). Cytochrome P450 isozyme induction by methyl ethyl ketone and m-xylene in rat liver. Toxicology and Applied Pharmacology. 103(1). 175–179. 20 indexed citations
15.
Nakajima, Tamie, et al.. (1989). Immunochemical characterization of cytochrome P-450 isozymes responsible for benzene oxidation in the rat liver. Carcinogenesis. 10(9). 1713–1717. 41 indexed citations
16.
Elovaara, Eivor, Antti Zitting, Juha Nickels, & Antero Aitio. (1987). m-Xylene inhalation destroys cytochrome P-450 in rat lung at low exposure. Archives of Toxicology. 61(1). 21–26. 18 indexed citations
17.
Savolainen, H., Pirkko Pfäffli, & Eivor Elovaara. (1985). Blood and Brainn‐Pentanol in Inhalation Exposure. Acta Pharmacologica et Toxicologica. 56(3). 260–264. 1 indexed citations
18.
Legraverend, Catherine, et al.. (1984). DNA binding of [14C]styrene in isolated rat hepatocytes. Chemico-Biological Interactions. 51(1). 91–102. 3 indexed citations
19.
Elovaara, Eivor, H. Savolainen, Pirkko Pfäffli, & Harri Vainio. (1979). Effects of Subacute Toluene Inhalation on its Metabolism and Disposition in Rat. Archives of toxicology. Supplement. 345–348. 17 indexed citations
20.
Elovaara, Eivor, et al.. (1979). Embryotoxicity of acrolein, acrylonitrile and acryl-amide in developing chick embryos. Toxicology Letters. 4(2). 93–96. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026